Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.07)
# 1,328
Out of 5,012 analysts
822
Total ratings
42.6%
Success rate
1.45%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RIGL Rigel Pharmaceuticals | Reiterates: Buy | $57 | $27.44 | +107.73% | 27 | Oct 8, 2025 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $9.75 | +310.26% | 27 | Sep 30, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $120 | $59.83 | +100.57% | 50 | Sep 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $32.85 | +210.50% | 35 | Sep 29, 2025 | |
| GUTS Fractyl Health | Maintains: Buy | $9 → $8 | $1.44 | +455.56% | 2 | Sep 26, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $24 | $7.58 | +216.62% | 26 | Sep 25, 2025 | |
| BCDA BioCardia | Reiterates: Buy | $25 | $1.34 | +1,765.81% | 17 | Sep 22, 2025 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $2.46 | +550.41% | 30 | Sep 19, 2025 | |
| TVTX Travere Therapeutics | Reiterates: Buy | $47 | $24.90 | +88.76% | 5 | Sep 19, 2025 | |
| ATXS Astria Therapeutics | Maintains: Buy | $16 → $20 | $7.82 | +155.75% | 22 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.85 | - | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $185.69 | +29.25% | 34 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.44 | +177.78% | 23 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.76 | +184.09% | 18 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $18.78 | +11.84% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.50 | +500.00% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $17 | $3.00 | +466.67% | 4 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $26.89 | +56.19% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.58 | +2,485.32% | 16 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.28 | +777.19% | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $11.38 | +163.62% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $6.29 | +58.98% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.41 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.97 | +1,235.52% | 32 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $15.55 | +170.10% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.35 | +495.74% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $53 | $100.44 | -47.23% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.59 | +151.57% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.72 | +424.78% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.51 | +688.95% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $4.75 | +26.39% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.43 | +486.91% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.97 | +407.61% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.78 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $37.60 | +176.60% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.10 | +190.13% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.64 | +938.17% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $13.99 | +128.73% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.15 | +407.94% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $11.02 | +2,168.60% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.77 | +1,074.93% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.73 | +940.46% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $3.60 | +566.67% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $10.72 | +49.24% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $13.79 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $8.90 | +248.31% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.27 | +844.88% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.47 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $14.31 | +158.63% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.67 | +560.66% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.46 | +1,269.86% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.04 | +722.18% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.69 | +5,831.20% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.81 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $0.20 | +16,127.18% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.89 | +1,487.30% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.88 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $35.19 | -6.22% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $8.95 | +771.51% | 1 | Mar 24, 2017 |
Rigel Pharmaceuticals
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $27.44
Upside: +107.73%
Kura Oncology
Sep 30, 2025
Reiterates: Buy
Price Target: $40
Current: $9.75
Upside: +310.26%
Cytokinetics
Sep 29, 2025
Reiterates: Buy
Price Target: $120
Current: $59.83
Upside: +100.57%
Viking Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $102
Current: $32.85
Upside: +210.50%
Fractyl Health
Sep 26, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.44
Upside: +455.56%
Capricor Therapeutics
Sep 25, 2025
Reiterates: Buy
Price Target: $24
Current: $7.58
Upside: +216.62%
BioCardia
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.34
Upside: +1,765.81%
Esperion Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.46
Upside: +550.41%
Travere Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $47
Current: $24.90
Upside: +88.76%
Astria Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $7.82
Upside: +155.75%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.85
Upside: -
Sep 15, 2025
Reiterates: Buy
Price Target: $240
Current: $185.69
Upside: +29.25%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.44
Upside: +177.78%
Sep 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
Aug 26, 2025
Reiterates: Buy
Price Target: $21
Current: $18.78
Upside: +11.84%
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $2.50
Upside: +500.00%
Aug 21, 2025
Maintains: Buy
Price Target: $26 → $17
Current: $3.00
Upside: +466.67%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $26.89
Upside: +56.19%
Aug 20, 2025
Reiterates: Buy
Price Target: $15
Current: $0.58
Upside: +2,485.32%
Aug 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.28
Upside: +777.19%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $11.38
Upside: +163.62%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $6.29
Upside: +58.98%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $0.97
Upside: +1,235.52%
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $15.55
Upside: +170.10%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.35
Upside: +495.74%
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $100.44
Upside: -47.23%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.59
Upside: +151.57%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.72
Upside: +424.78%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.51
Upside: +688.95%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $4.75
Upside: +26.39%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $4.43
Upside: +486.91%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.97
Upside: +407.61%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.78
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $37.60
Upside: +176.60%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.10
Upside: +190.13%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.64
Upside: +938.17%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $13.99
Upside: +128.73%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $3.15
Upside: +407.94%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $11.02
Upside: +2,168.60%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.77
Upside: +1,074.93%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.73
Upside: +940.46%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $3.60
Upside: +566.67%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $10.72
Upside: +49.24%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $13.79
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $8.90
Upside: +248.31%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $1.27
Upside: +844.88%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.47
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $14.31
Upside: +158.63%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.67
Upside: +560.66%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.46
Upside: +1,269.86%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.04
Upside: +722.18%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.69
Upside: +5,831.20%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.81
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $0.20
Upside: +16,127.18%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.89
Upside: +1,487.30%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.88
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $35.19
Upside: -6.22%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $8.95
Upside: +771.51%